Titlebook: Current Directions in Radiopharmaceutical Research and Development; Stephen J. Mather Book 1996 Kluwer Academic Publishers 1996 CNS.cell.c

ergonomics

書目名稱Current Directions in Radiopharmaceutical Research and Development影響因子(影響力)




書目名稱Current Directions in Radiopharmaceutical Research and Development影響因子(影響力)學科排名




書目名稱Current Directions in Radiopharmaceutical Research and Development網絡公開度




書目名稱Current Directions in Radiopharmaceutical Research and Development網絡公開度學科排名




書目名稱Current Directions in Radiopharmaceutical Research and Development被引頻次




書目名稱Current Directions in Radiopharmaceutical Research and Development被引頻次學科排名




書目名稱Current Directions in Radiopharmaceutical Research and Development年度引用




書目名稱Current Directions in Radiopharmaceutical Research and Development年度引用學科排名




書目名稱Current Directions in Radiopharmaceutical Research and Development讀者反饋




書目名稱Current Directions in Radiopharmaceutical Research and Development讀者反饋學科排名

Lucubrate

BOAST

The Development of Radiopharmaceuticals for Imaging CNS Receptors,ciation constant; or K., inhibition constant). When a ligand is bound to a receptor (R) located in the cell membrane, the ligand-receptor complex triggers responses of secondary messengers (i.e., induce protein kinase activity). There is a large number of CNS receptors responsible for different types of neuronal function.

感激小女

Computer Modelling of Metal-Based Radiopharmaceuticals,raphics. Most of these packages also make possible wave-mechanical calculations, which are useful in predicting properties such as electronic spectra, and magnetic properties. A selection of computer molecular modelling packages is listed below:

富足女人

標準

標準

Maria Lodovica Gullino,Laura Vivanimed by the “zippering” of two complementary single-stranded oligonucleotides by Watson-Crick base pairing can be termed hybridization [1]. It is this property of hybridization, unique to RNA and DNA (if artificial oligomers are excluded), which is likely to render in the near future radiolabeled oligonucleotides useful as radiopharmaceuticals.

緩和

Bifunctional Chelators for Technetium-99m,ociated with technetium is the fact that it cannot simply replace a hydrogen atom as it is the case with halogens like .I and .F, nor can be a substitute for one of the other common atoms in biologically interesting compounds, i.e. carbon, nitrogen or oxygen.

Anguish

Therapeutic Radionuclides: Making the Right Choice,chniques that have recently emerged, (e.g., tumor therapy with radiolabeled monoclonal antibodies, treatment of metastatic bone pain, etc.) appear to have provided a substantial impetus to research on production of new therapeutic radionuclides (4–7).

indices

Labelling Oligonucleotides with Imagable Radionuclides,med by the “zippering” of two complementary single-stranded oligonucleotides by Watson-Crick base pairing can be termed hybridization [1]. It is this property of hybridization, unique to RNA and DNA (if artificial oligomers are excluded), which is likely to render in the near future radiolabeled oligonucleotides useful as radiopharmaceuticals.